Appelbe, O. K., Q. Zhang, C. A. Pelizzari, R. R. Weichselbaum, and S. J. Kron. "Image-Guided Radiotherapy Targets Macromolecules through Altering the Tumor Microenvironment." Mol Pharm 13, no. 10 (Oct 3 2016): 3457-67.
Banuelos, J., S. Shin, Y. Cao, B. S. Bochner, L. Morales-Nebreda, G. R. Budinger, L. Zhou, et al. "Bcl-2 Protects Human and Mouse Th17 Cells from Glucocorticoid-Induced Apoptosis." Allergy 71, no. 5 (May 2016): 640-50.
Baxter, K. J., N. Govsyeyev, J. P. Namm, R. J. Gonzalez, K. K. Roggin, and K. Cardona. "Is Multimodality Therapy Necessary for the Management of Pure Myxoid Liposarcomas? A Multi-Institutional Series of Pure Myxoid Liposarcomas of the Extremities and Torso." J Surg Oncol 111, no. 2 (Feb 2015): 146-51.
Blein, S., C. Bardel, V. Danjean, L. McGuffog, S. Healey, D. Barrowdale, A. Lee, et al. "An Original Phylogenetic Approach Identified Mitochondrial Haplogroup T1a1 as Inversely Associated with Breast Cancer Risk in Brca2 Mutation Carriers." Breast Cancer Res 17 (Apr 25 2015): 61.
Brand, T. M., M. Iida, A. P. Stein, K. L. Corrigan, C. M. Braverman, J. P. Coan, H. E. Pearson, et al. "Axl Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma." Clin Cancer Res 21, no. 11 (Jun 1 2015): 2601-12.
Catenacci, D. V., M. R. Junttila, T. Karrison, N. Bahary, M. N. Horiba, S. R. Nattam, R. Marsh, et al. "Randomized Phase Ib/Ii Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients with Metastatic Pancreatic Cancer." J Clin Oncol 33, no. 36 (Dec 20 2015): 4284-92.
Catenacci, D. V., W. L. Liao, L. Zhao, E. Whitcomb, L. Henderson, E. O'Day, P. Xu, et al. "Mass-Spectrometry-Based Quantitation of Her2 in Gastroesophageal Tumor Tissue: Comparison to Ihc and Fish." Gastric Cancer 19, no. 4 (Oct 2016): 1066-79.
Chapman, C. G., C. J. Mariani, F. Wu, K. Meckel, F. Butun, A. Chuang, J. Madzo, et al. "Corrigendum: Tet-Catalyzed 5-Hydroxymethylcytosine Regulates Gene Expression in Differentiating Colonocytes and Colon Cancer." Sci Rep 6 (Apr 28 2016): 24963.
Chastkofsky, M. I., W. Bie, S. M. Ball-Kell, Y. Y. He, and A. L. Tyner. "Protein Tyrosine Kinase 6 Regulates Uvb-Induced Signaling and Tumorigenesis in Mouse Skin." J Invest Dermatol 135, no. 10 (Oct 2015): 2492-501.
Choudhury, N. J., A. Campanile, T. Antic, K. L. Yap, C. A. Fitzpatrick, J. L. Wade, 3rd, T. Karrison, et al. "Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients with Erbb Alterations." J Clin Oncol 34, no. 18 (Jun 20 2016): 2165-71.
Choueiri, T. K., M. N. Fishman, B. Escudier, D. F. McDermott, C. G. Drake, H. Kluger, W. M. Stadler, et al. "Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma." Clin Cancer Res (May 11 2016).
Churpek, J. E., K. Pyrtel, K. L. Kanchi, J. Shao, D. Koboldt, C. A. Miller, D. Shen, et al. "Genomic Analysis of Germ Line and Somatic Variants in Familial Myelodysplasia/Acute Myeloid Leukemia." Blood 126, no. 22 (Nov 26 2015): 2484-90.
Coveler, A. L., A. H. Ko, D. V. Catenacci, D. Von Hoff, C. Becerra, N. C. Whiting, J. Yang, and B. Wolpin. "A Phase 1 Clinical Trial of Asg-5me, a Novel Drug-Antibody Conjugate Targeting Slc44a4, in Patients with Advanced Pancreatic and Gastric Cancers." Invest New Drugs 34, no. 3 (Jun 2016): 319-28.
Eckert, M. A., S. Pan, K. M. Hernandez, R. M. Loth, J. Andrade, S. L. Volchenboum, P. Faber, et al. "Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube." Cancer Discov 6, no. 12 (Dec 2016): 1342-51.
Efimova, E. V., S. Takahashi, N. A. Shamsi, D. Wu, E. Labay, O. A. Ulanovskaya, R. R. Weichselbaum, S. A. Kozmin, and S. J. Kron. "Linking Cancer Metabolism to DNA Repair and Accelerated Senescence." Mol Cancer Res 14, no. 2 (Feb 2016): 173-84.
Forero-Torres, A., K. E. Varley, V. G. Abramson, Y. Li, C. Vaklavas, N. U. Lin, M. C. Liu, et al. "Tbcrc 019: A Phase Ii Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer." Clin Cancer Res 21, no. 12 (Jun 15 2015): 2722-9.
Gondal, B., P. Patel, A. Gallan, J. Hart, and M. Bissonnette. "Immune--Mediated Colitis with Novel Immunotherapy: Pd-1 Inhibitor Associated Gastrointestinal Toxicity." Acta Gastroenterol Belg 79, no. 2 (Jul-Sep 2016): 379-81.
He, C., X. Duan, N. Guo, C. Chan, C. Poon, R. R. Weichselbaum, and W. Lin. "Core-Shell Nanoscale Coordination Polymers Combine Chemotherapy and Photodynamic Therapy to Potentiate Checkpoint Blockade Cancer Immunotherapy." Nat Commun 7 (Aug 17 2016): 12499.
Jen, J., L. L. Lin, H. T. Chen, S. Y. Liao, F. Y. Lo, Y. A. Tang, W. C. Su, et al. "Oncoprotein Znf322a Transcriptionally Deregulates Alpha-Adducin, Cyclin D1 and P53 to Promote Tumor Growth and Metastasis in Lung Cancer." Oncogene 35, no. 18 (May 05 2016): 2357-69.
Keck, M. K., Z. Zuo, A. Khattri, T. P. Stricker, C. D. Brown, M. Imanguli, D. Rieke, et al. "Integrative Analysis of Head and Neck Cancer Identifies Two Biologically Distinct Hpv and Three Non-Hpv Subtypes." Clin Cancer Res 21, no. 4 (Feb 15 2015): 870-81.
Khammanivong, A., B. S. Sorenson, K. F. Ross, E. B. Dickerson, R. Hasina, M. W. Lingen, and M. C. Herzberg. "Involvement of Calprotectin (S100a8/A9) in Molecular Pathways Associated with Hnscc." Oncotarget 7, no. 12 (Mar 22 2016): 14029-47.
Kuchenbaecker, K. B., S. J. Ramus, J. Tyrer, A. Lee, H. C. Shen, J. Beesley, K. Lawrenson, et al. "Identification of Six New Susceptibility Loci for Invasive Epithelial Ovarian Cancer." Nat Genet 47, no. 2 (Feb 2015): 164-71.
Labay, E., H. J. Mauceri, E. V. Efimova, A. C. Flor, H. G. Sutton, S. J. Kron, and R. R. Weichselbaum. "Repurposing Cephalosporin Antibiotics as Pro-Senescent Radiosensitizers." Oncotarget 7, no. 23 (Jun 7 2016): 33919-33.
Lewinsohn, M., A. L. Brown, L. M. Weinel, C. Phung, G. Rafidi, M. K. Lee, A. W. Schreiber, et al. "Novel Germ Line Ddx41 Mutations Define Families with a Lower Age of Mds/Aml Onset and Lymphoid Malignancies." Blood 127, no. 8 (Feb 25 2016): 1017-23.
Liu, X., I. L. Romero, L. M. Litchfield, E. Lengyel, and J. W. Locasale. "Metformin Targets Central Carbon Metabolism and Reveals Mitochondrial Requirements in Human Cancers." Cell Metab 24, no. 5 (Nov 08 2016): 728-39.
Lu, K., C. He, N. Guo, C. Chan, K. Ni, R. R. Weichselbaum, and W. Lin. "Chlorin-Based Nanoscale Metal-Organic Framework Systemically Rejects Colorectal Cancers Via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy." J Am Chem Soc 138, no. 38 (Sep 28 2016): 12502-10.
Meckel, K., Y. C. Li, J. Lim, M. Kocherginsky, C. Weber, A. Almoghrabi, X. Chen, et al. "Serum 25-Hydroxyvitamin D Concentration Is Inversely Associated with Mucosal Inflammation in Patients with Ulcerative Colitis." Am J Clin Nutr 104, no. 1 (Jul 2016): 113-20.
Ming, M., K. Soltani, C. R. Shea, X. Li, and Y. Y. He. "Dual Role of Sirt1 in Uvb-Induced Skin Tumorigenesis." Oncogene 34, no. 3 (Jan 15 2015): 357-63.
Mitri, Z., R. Nanda, K. Blackwell, C. M. Costelloe, I. Hood, C. Wei, A. M. Brewster, et al. "Tbcrc-010: Phase I/Ii Study of Dasatinib in Combination with Zoledronic Acid for the Treatment of Breast Cancer Bone Metastasis." Clin Cancer Res (May 10 2016).
Muro, K., H. C. Chung, V. Shankaran, R. Geva, D. Catenacci, S. Gupta, J. P. Eder, et al. "Pembrolizumab for Patients with Pd-L1-Positive Advanced Gastric Cancer (Keynote-012): A Multicentre, Open-Label, Phase 1b Trial." Lancet Oncol 17, no. 6 (Jun 2016): 717-26.
Mustafi, R., U. Dougherty, D. Mustafi, F. Ayaloglu-Butun, M. Fletcher, S. Adhikari, F. Sadiq, et al. "Adam17 Is a Tumor Promoter and Therapeutic Target in Western Diet-Associated Colon Cancer." Clin Cancer Res (Aug 3 2016).
Nanda, R., L. Q. Chow, E. C. Dees, R. Berger, S. Gupta, R. Geva, L. Pusztai, et al. "Pembrolizumab in Patients with Advanced Triple-Negative Breast Cancer: Phase Ib Keynote-012 Study." J Clin Oncol 34, no. 21 (Jul 20 2016): 2460-7.
Nanda, R., E. M. Stringer-Reasor, P. Saha, M. Kocherginsky, J. Gibson, B. Libao, P. C. Hoffman, et al. "A Randomized Phase I Trial of Nanoparticle Albumin-Bound Paclitaxel with or without Mifepristone for Advanced Breast Cancer." Springerplus 5, no. 1 (2016): 947.
Paoletti, C., Y. Li, M. C. Muniz, K. M. Kidwell, K. Aung, D. G. Thomas, M. E. Brown, et al. "Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase Ii Trial: Tbcrc 019." Clin Cancer Res 21, no. 12 (Jun 15 2015): 2771-9.
Park, J. W., M. C. Liu, D. Yee, C. Yau, L. J. van 't Veer, W. F. Symmans, M. Paoloni, et al. "Adaptive Randomization of Neratinib in Early Breast Cancer." N Engl J Med 375, no. 1 (Jul 7 2016): 11-22.
Qiang, L., P. Shah, M. H. Barcellos-Hoff, and Y. Y. He. "Tgf-Beta Signaling Links E-Cadherin Loss to Suppression of Nucleotide Excision Repair." Oncogene 35, no. 25 (Jun 23 2016): 3293-302.
Qiang, L., B. Zhao, P. Shah, A. Sample, S. Yang, and Y. Y. He. "Autophagy Positively Regulates DNA Damage Recognition by Nucleotide Excision Repair." Autophagy 12, no. 2 (2016): 357-68.
Rugo, H. S., O. I. Olopade, A. DeMichele, C. Yau, L. J. van 't Veer, M. B. Buxton, M. Hogarth, et al. "Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer." N Engl J Med 375, no. 1 (Jul 7 2016): 23-34.
Schechter, R. B., M. Nagilla, L. Joseph, P. Reddy, A. Khattri, S. Watson, L. D. Locati, et al. "Genetic Profiling of Advanced Radioactive Iodine-Resistant Differentiated Thyroid Cancer and Correlation with Axitinib Efficacy." Cancer Lett 359, no. 2 (Apr 10 2015): 269-74.
Sehdev, A., Y. C. Shih, B. Vekhter, M. B. Bissonnette, O. I. Olopade, and B. N. Polite. "Metformin for Primary Colorectal Cancer Prevention in Patients with Diabetes: A Case-Control Study in a Us Population." Cancer 121, no. 7 (Apr 1 2015): 1071-8.
Seiwert, T. Y., Z. Zuo, M. K. Keck, A. Khattri, C. S. Pedamallu, T. Stricker, C. Brown, et al. "Integrative and Comparative Genomic Analysis of Hpv-Positive and Hpv-Negative Head and Neck Squamous Cell Carcinomas." Clin Cancer Res 21, no. 3 (Feb 1 2015): 632-41.
Sellappan, S., A. Blackler, W. L. Liao, E. O'Day, P. Xu, S. Thyparambil, F. Cecchi, T. Hembrough, and D. V. Catenacci. "Therapeutically Induced Changes in Her2, Her3, and Egfr Protein Expression for Treatment Guidance." J Natl Compr Canc Netw 14, no. 5 (May 2016): 503-7.
Shi, Y., T. Liu, L. He, U. Dougherty, L. Chen, S. Adhikari, L. Alpert, et al. "Activation of the Renin-Angiotensin System Promotes Colitis Development." Sci Rep 6 (Jun 08 2016): 27552.
Stoddart, A., Z. Qian, A. A. Fernald, R. J. Bergerson, J. Wang, T. Karrison, J. Anastasi, et al. "Retroviral Insertional Mutagenesis Identifies the Del(5q) Genes, Cxxc5, Tifab and Etf1, as Well as the Wnt Pathway, as Potential Targets in Del(5q) Myeloid Neoplasms." Haematologica 101, no. 6 (Jun 2016): e232-6.
Stringer-Reasor, E. M., G. M. Baker, M. N. Skor, M. Kocherginsky, E. Lengyel, G. F. Fleming, and S. D. Conzen. "Glucocorticoid Receptor Activation Inhibits Chemotherapy-Induced Cell Death in High-Grade Serous Ovarian Carcinoma." Gynecol Oncol 138, no. 3 (Sep 2015): 656-62.
Sur, M. D., J. P. Namm, J. A. Hemmerich, M. M. Buschmann, K. K. Roggin, and W. Dale. "Radiographic Sarcopenia and Self-Reported Exhaustion Independently Predict Nsqip Serious Complications after Pancreaticoduodenectomy in Older Adults." Ann Surg Oncol 22, no. 12 (Nov 2015): 3897-904.
Tao, Y., J. S. Messer, K. H. Goss, J. Hart, M. Bissonnette, and E. B. Chang. "Hsp70 Exerts Oncogenic Activity in the Apc Mutant Min Mouse Model." Carcinogenesis 37, no. 7 (Jul 2016): 731-9.
Visvanathan, K., M. S. Fackler, Z. Zhang, Z. A. Lopez-Bujanda, S. C. Jeter, L. J. Sokoll, E. Garrett-Mayer, et al. "Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: Tbcrc 005 Prospective Biomarker Study." J Clin Oncol (Nov 21 2016): JCO2015662080.
Wan, J. Y., C. Z. Wang, Z. Liu, Q. H. Zhang, M. W. Musch, M. Bissonnette, E. B. Chang, et al. "Determination of American Ginseng Saponins and Their Metabolites in Human Plasma, Urine and Feces Samples by Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry." J Chromatogr B Analyt Technol Biomed Life Sci 1015-1016 (Mar 15 2016): 62-73.
William, W. N., Jr., V. Papadimitrakopoulou, J. J. Lee, L. Mao, E. E. Cohen, H. Y. Lin, A. M. Gillenwater, et al. "Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (Epoc) Randomized Clinical Trial." JAMA Oncol 2, no. 2 (Feb 2016): 209-16.
Xiao, H., A. Langerman, Y. Zhang, O. Khalid, S. Hu, C. X. Cao, M. W. Lingen, and D. T. Wong. "Quantitative Proteomic Analysis of Microdissected Oral Epithelium for Cancer Biomarker Discovery." Oral Oncol 51, no. 11 (Nov 2015): 1011-9.
Young, N. R., C. Soneru, J. Liu, T. A. Grushko, A. Hardeman, O. I. Olopade, A. Baum, F. Solca, and E. E. Cohen. "Afatinib Efficacy against Squamous Cell Carcinoma of the Head and Neck Cell Lines in Vitro and in Vivo." Target Oncol 10, no. 4 (Dec 2015): 501-8.
Zhang, L., T. Krausz, and R. M. DeMay. "A Pilot Study of Galectin-3, Hbme-1, and P27 Triple Immunostaining Pattern for Diagnosis of Indeterminate Thyroid Nodules in Cytology with Correlation to Histology." Appl Immunohistochem Mol Morphol 23, no. 7 (Aug 2015): 481-90.
Zhang, Y., S. K. Sriraman, H. A. Kenny, E. Luther, V. Torchilin, and E. Lengyel. "Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of a P-Glycoprotein Inhibitor and Paclitaxel in a Liposomal Platform." Mol Cancer Ther 15, no. 10 (Oct 2016): 2282-93.
Acknowledgement of core facility contributions in publications is appreciated.
Cancer Center members should cite the Cancer Center Support Grant (P30CA014599) when publishing any work assisted by this core facility.